NME1-NME2
Basic information
Region (hg38): 17:51153590-51171744
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (3 variants)
- Inborn genetic diseases (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NME1-NME2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 0 | |||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 0 | 0 | 2 | 2 | 1 |
Variants in NME1-NME2
This is a list of pathogenic ClinVar variants found in the NME1-NME2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-51154262-C-G | not specified | Benign (Jan 24, 2024) | ||
17-51154266-G-A | not specified | Benign (Jan 24, 2024) | ||
17-51154423-CT-C | Uncertain significance (-) | |||
17-51155675-C-A | NME1-NME2-related disorder | Likely benign (Aug 14, 2019) | ||
17-51161282-T-G | NME1-NME2-related disorder | Benign (May 14, 2018) | ||
17-51161675-C-A | not specified | Benign (Jan 24, 2024) | ||
17-51161814-C-T | not specified | Likely benign (Jul 19, 2023) | ||
17-51161838-A-G | not specified | Uncertain significance (Jul 06, 2021) | ||
17-51166866-G-C | not specified | Uncertain significance (Sep 10, 2024) | ||
17-51168327-G-T | not specified | Uncertain significance (May 24, 2024) | ||
17-51171505-T-C | Likely benign (Feb 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NME1-NME2 | protein_coding | protein_coding | ENST00000393193 | 7 | 18155 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.85e-9 | 0.166 | 125704 | 0 | 44 | 125748 | 0.000175 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.876 | 132 | 164 | 0.807 | 0.00000939 | 1743 |
Missense in Polyphen | 51 | 58.612 | 0.87013 | 592 | ||
Synonymous | 0.666 | 53 | 59.5 | 0.890 | 0.00000340 | 517 |
Loss of Function | 0.271 | 13 | 14.1 | 0.922 | 8.57e-7 | 145 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000150 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000763 | 0.000761 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000107 | 0.000105 |
Middle Eastern | 0.000763 | 0.000761 |
South Asian | 0.000361 | 0.000359 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate (By similarity). Negatively regulates Rho activity by interacting with AKAP13/LBC (PubMed:15249197). Acts as a transcriptional activator of the MYC gene; binds DNA non- specifically (PubMed:8392752, PubMed:19435876). Binds to both single-stranded guanine- and cytosine-rich strands within the nuclease hypersensitive element (NHE) III(1) region of the MYC gene promoter. Does not bind to duplex NHE III(1) (PubMed:19435876). Has G-quadruplex (G4) DNA-binding activity, which is independent of its nucleotide-binding and kinase activity. Binds both folded and unfolded G4 with similar low nanomolar affinities. Stabilizes folded G4s regardless of whether they are prefolded or not (PubMed:25679041). Exhibits histidine protein kinase activity (PubMed:20946858). {ECO:0000250|UniProtKB:P36010, ECO:0000269|PubMed:15249197, ECO:0000269|PubMed:19435876, ECO:0000269|PubMed:20946858, ECO:0000269|PubMed:25679041, ECO:0000269|PubMed:8392752}.;
- Pathway
- Pyrimidine metabolism - Homo sapiens (human);Drug metabolism - other enzymes - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Adefovir Dipivoxil Metabolism Pathway;GLUT-1 deficiency syndrome;Congenital disorder of glycosylation CDG-IId;Tenofovir Metabolism Pathway;Lactose Synthesis;Pyrimidine metabolism;Neutrophil degranulation;pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis;UTP and CTP <i>de novo</i> biosynthesis;endocytotic role of ndk phosphins and dynamin;Metabolism of nucleotides;Folate metabolism;purine deoxyribonucleosides salvage;Interconversion of nucleotide di- and triphosphates;Purine metabolism;Innate Immune System;Immune System;Metabolism;Pyrimidine metabolism;superpathway of pyrimidine ribonucleotides <i>de novo</i> biosynthesis;superpathway of pyrimidine deoxyribonucleoside salvage;Purine nucleotides nucleosides metabolism;CMP phosphorylation;superpathway of purine nucleotide salvage;Pyrimidine nucleotides nucleosides metabolism;pyrimidine deoxyribonucleotide phosphorylation;superpathway of pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis;pyrimidine deoxyribonucleotides biosynthesis from CTP;guanosine deoxyribonucleotides <i>de novo</i> biosynthesis;guanosine nucleotides <i>de novo</i> biosynthesis;adenosine deoxyribonucleotides <i>de novo</i> biosynthesis;guanosine ribonucleotides <i>de novo</i> biosynthesis;purine nucleotides <i>de novo</i> biosynthesis;Validated targets of C-MYC transcriptional activation
(Consensus)
Intolerance Scores
- loftool
- 0.636
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 28.63
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.508
- ghis
- 0.400
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.409
Mouse Genome Informatics
- Gene name
- Gm5566
- Phenotype